These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8694664)

  • 1. Antithrombotic strategy after total hip replacement. A cost-effectiveness analysis comparing prolonged oral anticoagulants with screening for deep vein thrombosis.
    Sarasin FP; Bounameaux H
    Arch Intern Med; 1996 Aug 12-26; 156(15):1661-8. PubMed ID: 8694664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for proximal deep venous thrombosis using B-mode venous ultrasonography following major hip surgery: implications for clinical management.
    Wicky J; Bongard O; Peter R; Simonovska S; Bounameaux H
    Vasa; 1994; 23(4):330-6. PubMed ID: 7817614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of prophylactic anticoagulation prolonged after hospital discharge following general surgery.
    Sarasin FP; Bounameaux H
    Arch Surg; 1996 Jul; 131(7):694-7; discussion 698. PubMed ID: 8678765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
    Dranitsaris G; Stumpo C; Smith R; Bartle W
    Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.
    Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Huet Y
    Lancet; 1996 Jul; 348(9022):224-8. PubMed ID: 8684199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacement.
    Hawkins DW; Langley PC; Krueger KP
    Am J Health Syst Pharm; 1997 May; 54(10):1185-90. PubMed ID: 9161627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
    Menzin J; Colditz GA; Regan MM; Richner RE; Oster G
    Arch Intern Med; 1995 Apr; 155(7):757-64. PubMed ID: 7695464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.
    Caprini JA; Arcelus JI; Motykie G; Kudrna JC; Mokhtee D; Reyna JJ
    J Vasc Surg; 1999 Nov; 30(5):813-20. PubMed ID: 10550178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of desirudin compared with a low molecular weight heparin in the prevention of deep vein thrombosis after total hip replacement surgery.
    Levin LA; Bergqvist D
    Pharmacoeconomics; 2001; 19(5 Pt 2):589-97. PubMed ID: 11465303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery.
    Etchells E; McLeod RS; Geerts W; Barton P; Detsky AS
    Arch Intern Med; 1999 Jun; 159(11):1221-8. PubMed ID: 10371230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.
    Gómez-Outes A; Rocha E; Martínez-González J; Kakkar VV
    Pharmacoeconomics; 2006; 24(1):81-92. PubMed ID: 16445305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
    Turpie AG
    Orthopedics; 1995 Jul; 18 Suppl():15-7. PubMed ID: 7479420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
    Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
    Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.